JP2008500337A5 - - Google Patents

Download PDF

Info

Publication number
JP2008500337A5
JP2008500337A5 JP2007514981A JP2007514981A JP2008500337A5 JP 2008500337 A5 JP2008500337 A5 JP 2008500337A5 JP 2007514981 A JP2007514981 A JP 2007514981A JP 2007514981 A JP2007514981 A JP 2007514981A JP 2008500337 A5 JP2008500337 A5 JP 2008500337A5
Authority
JP
Japan
Prior art keywords
amino
carbonyl
alkyl
phenyl
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2007514981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008500337A (ja
Filing date
Publication date
Priority claimed from SE0401342A external-priority patent/SE0401342D0/xx
Application filed filed Critical
Publication of JP2008500337A publication Critical patent/JP2008500337A/ja
Publication of JP2008500337A5 publication Critical patent/JP2008500337A5/ja
Abandoned legal-status Critical Current

Links

JP2007514981A 2004-05-25 2005-05-20 治療化合物 Abandoned JP2008500337A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401342A SE0401342D0 (sv) 2004-05-25 2004-05-25 Therapeutic compounds
PCT/SE2005/000754 WO2005115972A1 (en) 2004-05-25 2005-05-20 Therapeutic compounds

Publications (2)

Publication Number Publication Date
JP2008500337A JP2008500337A (ja) 2008-01-10
JP2008500337A5 true JP2008500337A5 (enExample) 2008-05-08

Family

ID=32589801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007514981A Abandoned JP2008500337A (ja) 2004-05-25 2005-05-20 治療化合物

Country Status (16)

Country Link
US (1) US20090018116A1 (enExample)
EP (1) EP1756044A1 (enExample)
JP (1) JP2008500337A (enExample)
CN (1) CN1989100A (enExample)
AR (1) AR049898A1 (enExample)
AU (1) AU2005247835A1 (enExample)
BR (1) BRPI0511532A (enExample)
CA (1) CA2565066A1 (enExample)
IL (1) IL179145A0 (enExample)
MX (1) MXPA06013536A (enExample)
NO (1) NO20065904L (enExample)
SE (1) SE0401342D0 (enExample)
TW (1) TW200539856A (enExample)
UY (1) UY28922A1 (enExample)
WO (1) WO2005115972A1 (enExample)
ZA (1) ZA200609542B (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2024349B1 (en) 2006-05-31 2017-08-02 AbbVie Inc. Compounds as cannabinoid receptor ligands and uses thereof
US8841334B2 (en) 2006-05-31 2014-09-23 Abbvie Inc. Compounds as cannabinoid receptor ligands and uses thereof
JP2010522760A (ja) 2007-03-28 2010-07-08 アボット・ラボラトリーズ カンナビノイド受容体リガンドとしての1,3−チアゾール−2(3h)−イリデン化合物
US7872033B2 (en) 2007-04-17 2011-01-18 Abbott Laboratories Compounds as cannabinoid receptor ligands
WO2008144360A1 (en) 2007-05-18 2008-11-27 Abbott Laboratories Novel compounds as cannabinoid receptor ligands
US8338623B2 (en) 2007-07-09 2012-12-25 Abbvie Inc. Compounds as cannabinoid receptor ligands
US9193713B2 (en) 2007-10-12 2015-11-24 Abbvie Inc. Compounds as cannabinoid receptor ligands
KR101343399B1 (ko) * 2008-01-08 2013-12-19 퍼듀 퍼머 엘피 통증 치료를 위한 카나비노이드 수용체에 대한 리간드로서의 프롤린 유사체
US8846730B2 (en) 2008-09-08 2014-09-30 Abbvie Inc. Compounds as cannabinoid receptor ligands
GB2463318A (en) * 2008-09-12 2010-03-17 Syngenta Participations Ag Preparation of anthranilamide derivatives containing a pyridinylpyrazole moiety
CA2737199A1 (en) 2008-09-16 2010-03-25 Abbott Laboratories Novel compounds as cannabinoid receptor ligands
PA8854001A1 (es) 2008-12-16 2010-07-27 Abbott Lab Compuestos novedosos como ligandos de receptores de canabinoides
EP2864291B1 (en) 2012-06-26 2016-10-05 Bayer Pharma Aktiengesellschaft N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, production and use thereof as medicinal products
KR20140011780A (ko) * 2012-07-19 2014-01-29 한미약품 주식회사 단백질 키나아제 저해활성을 갖는 이소퀴놀린-5-카복스아미드 유도체
CN104918612B (zh) * 2012-12-06 2019-10-25 巴鲁克斯布隆伯格研究所 作为抗hbv感染的抗病毒剂的官能化苯甲酰胺衍生物
GB201313664D0 (en) * 2013-07-31 2013-09-11 Univ Cardiff Bcl-3 inhibitors
EP3628374B1 (en) * 2014-07-31 2023-08-30 University College Cardiff Consultants Limited Bcl-3 inhibitors
MY195016A (en) 2014-08-04 2023-01-03 Nuevolution As Optionally Fused Heterocyclyl-Substituted Derivatives of Pyrimidine Useful for The Treatment of Inflammatory, Metabolic, Oncologic and Autoimmune Diseases
WO2016115013A1 (en) * 2015-01-12 2016-07-21 Janssen Pharmaceutica Nv Cinnoline derivatives useful as cb-1 receptor inverse agonists
CN107709314A (zh) 2015-06-11 2018-02-16 巴斯利尔药物国际股份公司 外排泵抑制剂及其治疗性用途
EP3762379A1 (en) 2018-03-07 2021-01-13 Bayer Aktiengesellschaft Identification and use of erk5 inhibitors
WO2020234103A1 (en) 2019-05-21 2020-11-26 Bayer Aktiengesellschaft Identification and use of kras inhibitors
JP7478251B2 (ja) * 2019-12-14 2024-05-02 シャンハイ イースト ホスピタル(イースト ホスピタル,トンジ ユニバーシティ スクール オブ メディシン) イオンチャネルアンタゴニスト/遮断剤およびその用途
AU2020405446A1 (en) 2019-12-20 2022-05-26 Nuevolution A/S Compounds active towards nuclear receptors
BR112022012205A2 (pt) 2019-12-20 2022-09-13 Nuevolution As Compostos ativos para receptores nucleares
WO2021152113A1 (en) 2020-01-31 2021-08-05 Bayer Aktiengesellschaft Substituted 2,3-benzodiazepines derivatives
JP7713954B2 (ja) 2020-03-31 2025-07-28 ヌエヴォリューション・アクティーゼルスカブ 核内受容体に対して活性な化合物
CA3174252A1 (en) 2020-03-31 2021-10-07 Nuevolution A/S Compounds active towards nuclear receptors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166627D1 (en) * 1980-12-12 1984-11-15 Thomae Gmbh Dr K Pyrimidones, their preparation and medicines containing them
KR0167349B1 (ko) * 1989-10-20 1999-02-18 오스카 아끼히꼬 벤조헤테로 고리 화합물
DE19648793A1 (de) * 1996-11-26 1998-05-28 Basf Ag Neue Benzamide und deren Anwendung
MY138097A (en) * 2000-03-22 2009-04-30 Du Pont Insecticidal anthranilamides
ATE374765T1 (de) * 2000-07-27 2007-10-15 Lilly Co Eli Substituierte heterocyclische amide
CA2442654A1 (en) * 2001-04-10 2002-10-10 Transtech Pharma, Inc. Probes, systems, and methods for drug discovery
GB0222493D0 (en) * 2002-09-27 2002-11-06 Glaxo Group Ltd Compounds
US20060089398A1 (en) * 2003-03-19 2006-04-27 Gang Liu Isoxazole carboxamide derivatives as ghrelin receptor modulators

Similar Documents

Publication Publication Date Title
RU2595902C2 (ru) Замещенные бензамидные производные
RU2709207C2 (ru) 1,3,4-оксадиазольные производные соединения в качестве ингибитора гистондеацетилазы 6 и фармацевтическая композиция, содержащая их
AU2004281215B2 (en) Derivatives of N-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
ES2423851T3 (es) Compuesto de aciltiourea o sal del mismo y uso del mismo
RU2475487C2 (ru) Имидазохинолины с иммуномодулирующими свойствами
TWI450893B (zh) Inhibition of prostaglandin D synthase in the piper Compounds
JPWO2006030975A1 (ja) ピペリジン誘導体およびその用途
JPWO2004046110A1 (ja) メラニン凝集ホルモン受容体拮抗剤
US20090018116A1 (en) Therapeutic Compounds
NZ614305A (en) Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
US20070010529A1 (en) Nitrogenous heterocyclic compounds and medical use thereof
JPWO2010032856A1 (ja) 含窒素複素環化合物およびその用途
US8012981B2 (en) Benzylpiperazine derivatives as motilin receptor agonists
RU2009138219A (ru) Новые бензамидные производные и способ их получения
NZ552501A (en) Novel cyclic aminobenzoic acid derivative
RU2006144867A (ru) Производные тиенопиридинона и способы лечения
JP2005526797A (ja) ケモカイン受容体活性(特にccr5)のモジュレーターとして有用なピペリジンまたは8−アザ−ビシクロ[3.2.1]オクタ−3−イル誘導体
NO20084674L (no) 1- [ (4-(benzoyl (metyl) amino] -3- (fenyl) butyl] azetidinderivater for behandling av gastrointestinale lidelser
JP2010506910A5 (enExample)
ES2286474T3 (es) Derivados de 4-(finilpiperazinilmetil) benzamida y su uso para el tratamiento de dolor o transtornos gastrointestinales.
US20100179118A1 (en) Cyclic aminoalkylcarboxamide derivative
ES2390812T3 (es) Derivados de bencilpiperazina útiles para el tratamiento de trastornos gastrointestinales
JP2008500335A5 (enExample)
US7521449B2 (en) 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof
RU2008105987A (ru) Новые пиперидиновые производные